The association of metabolic syndrome components and diabetes mellitus: evidence from China National Stroke Screening and Prevention Project

Table 2 Odds and 95% Confidence Interval (CI) of Diabetes Mellitus for MetS and the Number of Components of MetS by the NCEP, AHA and IDF Criteria

	DM(n = 15,799)
	Crude OR(95% CI)	AdjOR(95% CI)
MetS by different criteria(Ref. = Non-MetS)
NCEP ATP III	4.12 (3.98–4.26)	3.65 (3.52–3.79)
AHA/NHLBI	3.46 (3.34–3.58)	3.03 (2.92–3.14)
IDF	2.84 (2.74–2.93)	2.50 (2.41–2.60)
Subgroup of MetS(Ref. = Non-MetS)
MetS by IDF and NCEP ATP III	4.96 (4.77–5.17)	3.06 (2.94–3.18)
MetS by IDF and AHA/NHLBI	4.33 (4.16–4.51)	2.63 (2.53–2.73)
MetS by AHA/NHLBI and NCEP ATP III	4.11 (3.97–4.26)	3.65 (3.52–3.79)
Nunber of components of MetS by NCEP ATP III(Ref. = zero)
One	2.08 (1.87–2.32)	1.78 (1.59–1.98)
Two	5.24 (4.74–5.81)	4.35 (3.93–4.83)
Three	9.84 (8.88–10.91)	7.86 (7.08–8.72)
Four	18.24 (16.38–30.31)	13.93 (12.47–15.56)
Five	34.42 (30.03–39.46)	26.40 (22.90–30.43)
P for trend		< 0.001
Nunber of components of MetS by AHA/NHLBI(Ref. = zero)
One	2.48 (2.19–2.82)	2.11 (1.86–2.40)
Two	6.12 (5.42–6.90)	4.93 (4.36–5.57)
Three	10.60 (9.39–11.97)	8.17 (7.23–9.24)
Four	17.19 (15.18–19.46)	12.60 (11.10–14.30)
Five	26.18 (22.70–30.20)	19.10 (16.41–22.03)
P for trend		< 0.001
Nunber of components of MetS by IDF(Ref. = zero)
One	2.28 (1.95–2.67)	2.01 (1.72–2.36)
Two	4.70 (4.308–5.46)	3.88 (3.33–4.52)
Three	9.432 (8.13–10.95)	7.406.36–8.61)
Four	14.65 (12.60–17.03)	11.06 (9.49–12.88)
Five	26.57 (22.69–31.12)	18.81 (16.01–22.10)
P for trend		< 0.001

Adjusted for sex, age (40~49, 50~59, ≥60), marital status, education, physical activity (3 times/weeks and ≥ 30 min/times or is industrial and agricular labor), current smoking (yes, no), current drinking (yes, no), family history of diabetes mellitus
MetS metabolic syndrome, NCEP ATPIII National Cholesterol Education Program Third Adult Treatment Panel, AHA/NHLBI American Heart Association/National Heart, Lung, and Blood Institute, IDF International Diabetes Federation, HDL high-density lipoprotein, Ref reference
For NCEP ATP III criterion, component one to five are one or more of five components including central obesity (waist≥102/88), elevated BP, hypertriglyceridemia, low HDL and hyperglycemia (glucose≥6.1); For AHA/NHLBI criterion, component one to five are one or more of five components including central obesity (waist≥102/88), elevated BP, hypertriglyceridemia, low HDL and hyperglycemia (glucose≥5.6); For IDF criterion, component one to five are one or more of five components including central obesity (waist≥90/80), hypertriglyceridemia, elevated BP, low HDL and hyperglycemia (glucose≥5.6)

ISSN: 1471-2458